Stockreport

CervoMed to Participate in 3rd Annual ROTH Healthcare Opportunities Conference

CervoMed Inc.  (CRVO) 
PDF BOSTON, Oct. 02, 2024 (GLOBE NEWSWIRE) -- CervoMed Inc. (NASDAQ: CRVO), a clinical-stage company focused on developing treatments for age-related neurologic disorders, [Read more]